Brainerd, Minnesota Clinical Trials

A listing of Brainerd, Minnesota clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 21 clinical trials
Featured trial
ARE YOU CARING FOR A LOVED ONE WITH DEMENTIA OR MCI?

You may be eligible to participate in a research study for caregivers of people with dementia or mild cognitive impairment. The study is titled: AI Bots and Wearables for Dementia Caregivers to Improve Quality of Life, and is being conducted by Gene Wang from Care Daily.

Online studies
Care Daily
(online study) Contact site
  • 23 views
  • 25 May, 2023
  • 1 location
  • Online study
Featured trial
The Southern California Caregiver Study

Seeking volunteers to participate in a research study for persons caring for family members with memory loss, dementia, or Alzheimer's. We want to test two different types of classes to see if one or both are just as beneficial in helping caregivers care for a family member with memory loss.

Accepts healthy volunteers
Online studies
Online Study Center
(online study) Contact site
  • 79 views
  • 18 May, 2023
  • 1 location
  • Online study
S0820, Adenoma and Second Primary Prevention Trial (PACES)

The investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and second primary colorectal cancers in patients previously treated for Stages 0 through III colon or rectal cancer.

rectal carcinoma
unstable angina
anticoagulants
aspirin
adenoma
Riverwood Healthcare Center
 (23.4 away) Contact site
  • 2953 views
  • 04 Oct, 2022
  • +407 other locations
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

This phase III trial studies how well an antibody (durvalumab) with chemotherapy and radiation therapy (chemoradiation) works in treating patients with stage III non-small cell lung cancer that cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, …

carboplatin
durvalumab
mitomycin
neutrophil count
paclitaxel
Essentia Health Saint Joseph's Medical Center
 (4.8 away) Contact site
  • 160 views
  • 11 Apr, 2023
  • +545 other locations
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may …

absolute neutrophil count
liver metastasis
immunomodulators
ipilimumab
colony-stimulating factors
Essentia Health Saint Joseph's Medical Center
 (4.8 away) Contact site
  • 169 views
  • 07 Apr, 2023
  • +428 other locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

pembrolizumab
carboplatin
erlotinib
cancer
paclitaxel
Riverwood Healthcare Center
 (23.4 away) Contact site
  • 1154 views
  • 03 Apr, 2023
  • +1020 other locations
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

This phase III trial studies whether pembrolizumab alone as a first-line treatment, followed by pemetrexed and carboplatin with or without pembrolizumab after disease progression is superior to induction with pembrolizumab, pemetrexed and carboplatin followed by pembrolizumab and pemetrexed maintenance in treating patients with stage IV non-squamous non-small cell lung cancer. …

hepatitis c virus
brain metastases
leptomeningeal disease
chronic hepatitis b
oophorectomy
Essentia Health Saint Joseph's Medical Center
 (4.8 away) Contact site
  • 327 views
  • 04 Apr, 2023
  • +769 other locations
A Randomized Phase II Study De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)

This phase II trial studies how well lower-dose chemotherapy plus radiation (chemoradiation) therapy works in comparison to standard-dose chemoradiation in treating patients with early-stage anal cancer. Drugs used in chemotherapy, such as mitomycin, fluorouracil, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing …

Essentia Health Saint Joseph's Medical Center
 (4.8 away) Contact site
  • 215 views
  • 23 Oct, 2022
  • +363 other locations
A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma

This phase II trial compares three chemotherapy regimens consisting of bendamustine, rituximab, high dose cytarabine, and acalabrutinib and studies how well they work in treating patients with newly diagnosed mantle cell lymphoma. Drugs used in chemotherapy, such as bendamustine and cytarabine, work in different ways to stop the growth of …

cyclin d1
vitamin k antagonists
bendamustine
anemia
measurable disease
Essentia Health Saint Joseph's Medical Center
 (4.8 away) Contact site
  • 67 views
  • 04 Oct, 2022
  • +302 other locations
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important …

cardiac arrhythmia
metastasis
biomarker analysis
mitomycin
angina
Riverwood Healthcare Center
 (22.4 away) Contact site
  • 433 views
  • 04 Oct, 2022
  • +939 other locations